期刊文献+

氟涂层镁铝合金的体外生物相容性研究 被引量:1

In vitro study on the biocompatibility of magnalium with fluorine coating
下载PDF
导出
摘要 目的研究氟涂层镁铝合金的体外生物相容性。方法实验分为空白对照组(N组)、镁铝合金组(M组)、氟涂层镁铝合金组(F组)和阳性对照组(P组)4组。细胞毒性实验:将L929细胞在各组的DMEM浸提液中培养,光学显微镜下观察细胞生长状况,应用WST-1法测量光密度(OD)值。溶血实验:按GB-T 16175-2008《医用有机硅材料生物学评价实验方法》第13部分《溶血试验》进行实验。测量各样本的OD值,计算溶血率。豚鼠最大剂量致敏实验,按照GB-T 16886.10-2005《医疗器械生物学评价》第10部分《刺激与迟发型超敏反应试验》进行实验。观察激发阶段去除贴附片后24、48、72h豚鼠皮肤致敏情况。结果各观察期F组的形态分级为0级,M组为4级。各组各观察期内OD值差异均有统计学意义(F=312.96,P=0.000)。第3天,实验组OD值均高于P组(1.050±0.065 vs 0.292±0.010)(P<0.05)。第5天、第7天,F组与N组OD值(1.429±0.096 vs 1.622±0.156,0.928±0.040 vs 0.995±0.070)处于同一水平(P>0.05),均高于P组(0.270±0.015,0.281±0.006)(P<0.05)。M组溶血率为68.3%,F组为0.8%。24 h、48 h和72 h后N组、M组、F组皮肤均无红斑。结论氟涂层镁铝合金体外实验显示具有良好的生物相容性。 Objective To study the biocompatibility of magnalium with fluorine coating in vitro. Methods The experiment included 4 groups: group blank control(group N), group magnalium(group M), group magnalium with fluorine coating(group F) and group positive control (group P). WST-1 assay was employed to evaluate the cytotoxicity of the material against L929 cells. Haemolysis experiment was performed in accordance with the 13th part of GB-T 16175 - 2008 Experiment Method of Biology Evaluation of Medical Organosilicon. The maximal dose sensitization experiment of Cavia was performed in accordance with the lOth part of GB-T 16886.10-2005 Experiment of Irritate and Delayed Hypersensitivity in Experiment Method of medical apparatus and instrument, and the conditions of Cavia skin sensitization was observed at 24-hour, 48-hour and 72-hour after sticking removal. Results The morphological grade of group F at each observation period was O, and that of group M was 4. The OD values of each group at each observation period were statistically different(F = 312.96, P = 0.000). At the 3rd day, the ODs of the experimental groups were higher than that of group P (1.050 ± 0.065 vs 0.292 ± 0.010)(P 〈 0.05). At the 5th and 7th day, the OD of group F and group N(1.429 ± 0.096 vs 1.622 ± 0.156, 0.928 ± 0.040 vs 0.995 ± 0.070) was at the same level(P 〉 0.05), but higher than that of group P (0.270 ± 0.015, 0.281 ± 0.006)(P 〈 0.05). The haemolysis rate of group M was 68.3 %, and that of group F was 0.8 %. The skin erythema were not found in group N, group M and group F at 24-hour, 48-hour and 72-hour. Conclusion It is demonstrated that favorable biocompatibility is observed in the in vitro experiment.
出处 《生物医学工程与临床》 CAS 2014年第2期101-105,共5页 Biomedical Engineering and Clinical Medicine
基金 国家自然科学基金资助(30872642) 全军"十二五"计划课题重点项目(BWS11C065)
关键词 镁合金 氟涂层 生物相容性 体外实验 Mg alloy fluorine coating biocompatibility experiment in vitro
  • 相关文献

参考文献11

  • 1Shaw BA. Corrosion resistance of magnesium alloys[M]//Steph- en D, Covino BS, editor. ASM handbook volume 13A: Corrosion: fundamentals, testing and protection. UK: ASM International, 2003: 692-696.
  • 2Drynda A, Hassel T, Hoehn R, et al. Development and biocomp- atibility of a novel corrodible fluoride- coated magnesium-calc- ium alloy with improved degradation kinetics and adequate me- chanical properties for cardiovascular applications[J]. J Biomed Mater Res A, 2010, 93(2): 763-775.
  • 3Xu L, Yu G, Zhang E, et al. In vivo corrosion behavior of Mg-M- n-Zn alloy for bone implant application[J]. J Biomed Mater Res A, 2007, 83(3): 703-711.
  • 4Gray-Munro JE, Seguin C, Strong M. Influence of surface modif- ication on the in vitro corrosion rate of magnesium alloy AZ3 l[J]. J Biomed Mater Res A, 2009, 91(1): 221-230.
  • 5Witte F, Fischer J, Nellesen J, et al. In vivo corrosion and corros- ion protection of magnesium alloy LAE442 [J]. Acta Biomater, 2010, 6(5): 1792-1799.
  • 6Wong HM, Yeung KW, Lam KO, etal. A biodegradable polym- er-based coating to control the performance of magnesium alloy orthopaedic implants[J]. Biomaterials, 2010, 31(8): 2084-2096.
  • 7Xin Y, Jiang J, Huo K, et al. Corrosion resistance and cytocomp- atibility of biodegradable surgical magnesium alloy coated with hydrogenated amorphous silicon [J]. J Biomed Mater Res A, 2009, 89(3): 717-726.
  • 8Xu L Zhang E, Yang K. Phosphating treatment and corrosion pr- operties of Mg-Mn-Zn alloy for biomedical application[J]. J Ma- ter Sci Mater Med, 2009, 20(4): 859-867.
  • 9Gu X, Zheng Y, Cheng Y, et aL In vitro corrosion and biocompat- ibility of binary magnesium alloys[J]. Biomaterials, 2009, 30 (4): 484-498.
  • 10Witte F, Fischer J, Nellesen J, et ol. In vitro and in vivo corro- sion measurements of magnesium alloys [J~. Biomaterials, 2006, 27(7): 1013-1018.

二级参考文献2

共引文献10

同被引文献17

  • 1Witte F, Kaese V, Haferkamp H, et al. In vivo corrosion of four magnesium alloys and the associated bone response[J]. Biomate-rials, 2005, 26(17): 3557-3563.
  • 2Zreiqat H, Howlett CR, Zannettino A, et al. Mechanisms of mag-nesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants[J]. J Biomed Mater Res, 2002, 62(2): 175-184.
  • 3Yamasaki Y, Yoshida Y, Okazaki M, et al. Synthesis of function-ally graded MgCO3 apatite accelerating osteoblast adhesion[J]. J Biomed Mater Res, 2002, 62(1): 99-105.
  • 4Yamasaki Y, Yoshida Y, Okazaki M, et al. Action of FGMgCO3-Ap-collagen composite in promoting bone formation[J]. Biom-aterials, 2003, 24(27): 4913-4920.
  • 5Shaw BA. Corrosion resistance of magnesium alloys[M]//Stephen D, editor. ASM handbook volume 13A corrosion: fundament-als, testing and protection. UK: ASM Int, 2003.
  • 6Kaesel V, Tai PT, Bach FW, et al. Approach to control the cor-rosion of magnesium by aUoying[C]//Kainer KU, editor. Magn esium: Proceedings of the sixth international conference magn-esium alloys and their applications. New York: Wiley-Vch,2004: 534-539.
  • 7Grey JE, Luan B. Protective coatings on magnesium and its alloys-a critical review[J]. Journal of Alloys and Compounds, 2002, 336(1-2): 88-113.
  • 8Witte F, Ulrich H, Rudert M, et al. Biodegradable magnesium s-caffolds: Part 1: appropriate inflammatory response[J]. J Biomed Mater Res A, 2007, 81(3): 748-756.
  • 9Witte F, Fischer J, Nellesen J, et al. In vivo corrosion and corros-ion protection of magnesium alloy LAE442 [J]. Acta Biomater, 2009, 6(5): 1792-1799.
  • 10Xu L, Pan F, Yu G, et al. In vitro and in vivo evaluation of the surface bioactivity of a calcium phosphate coated magnesium alloy[J]. Biomaterials, 2009, 30(8): 1512-1523.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部